MarketLens
Sign Up

Has Vanda Pharmaceuticals Finally Found Its Game-Changer with Bysanti

7 months ago
SHARE THIS ON:

Has Vanda Pharmaceuticals Finally Found Its Game-Changer with Bysanti

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 weeks ago

Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder

Vanda Pharmaceuticals reported positive Phase III results for HETLIOZ 20 mg in Delayed Sleep-Wake Phase Disorder, with sleep onset shifting 37.1 minutes earlier versus placebo (p=0.022). The study met...
Stock News•1 months ago

Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants

Roivant Sciences gains a commercial foundation after LISRAYA's recent approval, while brepocitinib could expand into a broader immunology franchise. The pulmonary candidate mosliciguat also shows prom...
Stock News•2 months ago

Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call Transcript

Vanda Pharmaceuticals reported Q2 2026 results, with revenue and earnings impacted by product performance and costs. The earnings call highlighted key operational updates and financial metrics for the...

Breaking News

View All →

Top Headlines

View More →
Stock News•49 minutes ago

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Prediction: Alphabet Will Soar After Oct. 28

Stock News•1 hour ago

Alphabet (GOOGL) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Why Alphabet Inc. (GOOG) Dipped More Than Broader Market Today

Stock News•2 hours ago

OpenAI claims ex-employee brought confidential docs about ‘unreleased device' to Apple